In vitro evaluation of regional nasal drug delivery using multiple anatomical nasal replicas of adult human subjects and two nasal sprays

被引:23
作者
Manniello, Michele Dario [1 ]
Hosseini, Sana [1 ]
Alfaifi, Ali [1 ,2 ]
Esmaeili, Amir R. [1 ]
Kolanjiyil, Arun, V [1 ]
Walenga, Ross [1 ]
Babiskin, Andrew [3 ]
Sandell, Dennis [4 ]
Mohammadi, Reza [1 ]
Schuman, Theodore [5 ]
Hindle, Michael [2 ]
Golshahi, Laleh [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Mech & Nucl Engn, Richmond, VA USA
[2] Virginia Commonwealth Univ, Dept Pharmaceut, Richmond, VA USA
[3] US FDA, Div Quantitat Methods & Modeling, Off Res & Stand, Off Gener Drugs,Ctr Drug Evaluat & Res, Silver Spring, MD USA
[4] S5Consulting, Blentarp, Sweden
[5] VCU Hlth, Dept Otolaryngol Head & Neck Surg, Richmond, VA USA
关键词
Anatomical variability; Drug deposition; In vitro bioequivalence; Nasal replica; Nasal spray; DEPOSITION; BIOEQUIVALENCE; ABSORPTION; PARAMETERS; SUSPENSION; CLEARANCE; PATTERNS; DESIGN; SHEAR;
D O I
10.1016/j.ijpharm.2020.120103
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Quantifying drug delivery to the site of action using locally-acting nasal suspension sprays is a challenging but important step toward understanding bioequivalence (BE) between test and reference products. The main objective of this study was to investigate the in vitro deposition pattern of two common but different locally-acting nasal suspension sprays using multiple nasal cavities. Twenty anatomically accurate nasal replicas were developed from high-resolution sinonasal computed tomography scans of adults with healthy nasal airways. The airways were segmented into two regions of anterior and posterior to the internal nasal valve. Both sides of the septum were considered separately; hence, 40 nasal cavities were studied. The positioning of the spray nozzle in all 40 cavities was characterized by the head angle, coronal angle, and the insertion depth. Despite using a controlled protocol to minimize the anterior losses, a wide range of variability in posterior drug delivery was observed. The observed intersubject variability using this in vitro method may have important implications for understanding BE of locally-acting nasal suspension sprays.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia
    Fais, Fabio
    Juskeviciene, Reda
    Francardo, Veronica
    Mateos, Stephanie
    Guyard, Manuela
    Viollet, Cecile
    Constant, Samuel
    Borelli, Massimo
    Hohenfeld, Ilja P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [42] A Novel Preparation Technique for Human Nasal Respiratory Mucosa to Disclose Its Glycosylation Pattern for Bioadhesive Drug Delivery
    Gausterer, Julia Clara
    Schlager, Michael
    Ahmadi, Navid
    Nieratschker, Michael
    Dahm, Valerie
    Wirth, Michael
    Arnoldner, Christoph
    Honeder, Clemens
    Gabor, Franz
    PHARMACEUTICS, 2023, 15 (03)
  • [43] Statistically Optimized Facile Development, Characterization and Evaluation of Niosomal Nasal Drug Delivery System of Ropinirole Hydrochloride: In vitro Drug Release, Cytotoxicity and ex vivo Permeability Studies
    Suryanarayana, Regulagadda
    Vinukonda, Anjaneyulu
    Saroj, Seema
    Jain, Neelu
    Pandey, Harish
    Rudrabhatla, V. S. A. Pavan
    Gode, Thrimurthulu
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2023, 57 (01) : 62 - 73
  • [44] Characterisation of nasal devices for delivery of insulin to the brain and evaluation in humans using functional magnetic resonance imaging
    Wingrove, Jed
    Swedrowska, Magda
    Scherliess, Regina
    Parry, Mark
    Ramjeeawon, Mervin
    Taylor, David
    Gauthier, Gregoire
    Brown, Louise
    Amiel, Stephanie
    Zelaya, Fernando
    Forbes, Ben
    JOURNAL OF CONTROLLED RELEASE, 2019, 302 : 140 - 147
  • [45] Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety
    Chatzitaki, Aikaterini-Theodora
    Jesus, Sandra
    Karavasili, Christina
    Andreadis, Dimitrios
    Fatouros, Dimitrios G.
    Borges, Olga
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 589
  • [46] Brain drug delivery from the nasal olfactory region is enhanced using lauroylcholine chloride: An estimation using in vivo PET imaging
    Fukakusa, Shota
    Suzuki, Chie
    Sasaki, Keita
    Sonoda, Yoh
    Hatano, Yoshiya
    Haruta, Shunji
    Magata, Yasuhiro
    NUCLEAR MEDICINE AND BIOLOGY, 2024, 138
  • [47] In Vitro Assessment of Nasal Insufflation of Comminuted Drug Products Designed as Abuse Deterrent Using the Vertical Diffusion Cell
    Boyce, Heather
    Smith, Dan
    Byrn, Steve
    Saluja, Bhawana
    Qu, Wen
    Gurvich, Vadim J.
    Hoag, Stephen W.
    AAPS PHARMSCITECH, 2018, 19 (04): : 1744 - 1757
  • [48] Impact of Airborne Particle Size, Acoustic Airflow and Breathing Pattern on Delivery of Nebulized Antibiotic into the Maxillary Sinuses Using a Realistic Human Nasal Replica
    Lara Leclerc
    Jérémie Pourchez
    Gérald Aubert
    Sandrine Leguellec
    Laurent Vecellio
    Michèle Cottier
    Marc Durand
    Pharmaceutical Research, 2014, 31 : 2335 - 2343
  • [49] Impact of Airborne Particle Size, Acoustic Airflow and Breathing Pattern on Delivery of Nebulized Antibiotic into the Maxillary Sinuses Using a Realistic Human Nasal Replica
    Leclerc, Lara
    Pourchez, Jeremie
    Aubert, Gerald
    Leguellec, Sandrine
    Vecellio, Laurent
    Cottier, Michele
    Durand, Marc
    PHARMACEUTICAL RESEARCH, 2014, 31 (09) : 2335 - 2343
  • [50] Development and Pharmacokinetic Evaluation of Novasomes for the Trans-nasal Delivery of Fluvoxamine Using Arachidonic Acid-Carboxymethyl Chitosan Conjugate
    Gulshan, Saima
    Shah, Shahid
    Shah, Pervaiz Akhtar
    Irfan, Muhammad
    Saadullah, Malik
    Abbas, Ghulam
    Hanif, Muhammad
    Rasul, Akhtar
    Ahmad, Nabeel
    Mahmood, Abid
    Basheer, Ejaz
    Habib, Mohammad Omer
    Alotaibi, Hadil Faris
    Obaidullah, Ahmad J.
    Alsabhan, Jawza F.
    Alwassil, Osama L.
    PHARMACEUTICS, 2023, 15 (09)